Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| FEDERAL MOGU | FDML | 8.53% |
| SCIENTIFIC L | SCIL | 8.00% |
| RADIANT LOGI | RLGT | 6.38% |
| SUMMER INFAN | SUMR | 5.42% |
| NATUS MEDICA | BABY | 5.13% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Red Robin Gourmet Burgers Inc. ( RRGB - Analyst Report ) , a chain of casual dining restaurants, is set to debut its first unit in Miami area, Florida, shortly. The new restaurant will be located at The Falls and will offer gourmet burgers served with Bottomless Steak Fries, a variety of salads, entrees, soups and wraps made with fresh ingredients. In Florida, the company already has six more restaurants.
Given customers’ inclination toward a fresh organic menu as well as concerns about nutrition these days, we believe integrity in ingredients will be a crucial factor for traffic growth. Apart from this, there will be other sales enhancement initiatives like a guest loyalty program called Red Royalty.
However, Seattle-based Red Robin will likely face stiff competition in that area because of the presence of several renowned eateries like Panera Bread Co. ( PNRA - Analyst Report ) , T.G.I. Friday’s, and PF Chang’s China Bistro Inc. ( ) .
Red Robin currently operates more than 460 restaurants across the United States and Canada. The company is also expanding through its franchise strategy. Currently, the restaurant chain is 70% company operated and 30% franchised.
The company expects to roll out 13 to 15 restaurants in 2012, including both full-sized restaurants and smaller prototype units. Small-size restaurants will likely drive growth in non-traditional locations and also improve return on invested capital. Red Robin’s units are mostly located in California, Colorado, North Carolina, Ohio, Virginia, and Washington. The company expects to open around 50% of its targeted restaurants in 2012 in these states. While the company seems comfortable expanding in familiar ground, we also foresee management expanding in relatively new markets to avoid market saturation.
Red Robin targets investment in the range of $50–$60 million in 2012 toward unit development. It also plans to increase investments in equipment and store remodeling.
Red Robin currently has a Zacks #1 Rank, which implies a Strong Buy rating over the short term. We reiterate our long-term Outperform recommendation on the stock.
Read the full Analyst Report on PNRA
Read the full Analyst Report on RRGB